Multidrug-resistant bacteria keep the medical world in suspense. Frequent forms are MRSA - bacteria. Much more aggressive are Klebsiella and Escherichia coli (EHEC), which increasingly constitute
Extended Spectrum Beta-lactamases, i.e. enzymes which can inactivate the beta lactam antibiotics. Wounds are bacteria´s favorite playground and this is where they mostly frequent.
Click on the text in order to find out more information on the "problem bacteria".
The WHO (World health Organization) has warned recently that more and more antibiotics are becoming increasingly ineffective. In the last few years registrations of new antibiotics have decreased
significantly. There have been only 2 substances with new mechanism of activity within 30 years. Why?
The search for new antibiotics has become synonymous to the classic expression "finding a needle in a haystack". Many of the pharmaceutical companies have opted from antibiotic research, for
obvious reasons such as costs but also because new antibiotics entering the market are not being used at the same extent as previously and even being locked away in order to prevent
Antimicrobial resistance (produced by FDA)
Mecanismos de resistencia (produced by FDA)